Home » GlaxoSmithKline, J&J to Start Rheumatoid Arthritis Drug Trial
GlaxoSmithKline, J&J to Start Rheumatoid Arthritis Drug Trial
GlaxoSmithKline and Johnson & Johnson’s Janssen Biologics said Thursday they have begun late-stage trial testing of a new treatment for moderately active to severely active rheumatoid arthritis.
Reuters
Reuters
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May